[Palmoplantar hyperkeratosis associated with losartan]
M Calvo1, M Fernández-Guarino, E Martín-Saez
1Servicio de Dermatología, Hospital Ramón y Cajal, Madrid, España. mcalvopulido@yahoo.es
Actas Dermo-Sifiliograficas
|September 19, 2006
Summary
Losartan, an angiotensin II receptor antagonist, can cause skin lesions. Withdrawal of the medication led to remission of palmoplantar lesions in a patient, suggesting a link.
Area of Science:
- Pharmacology
- Dermatology
- Cardiology
Background:
- Losartan is an angiotensin II receptor antagonist used for hypertension and heart failure.
- Angiotensin receptor antagonists can affect the local renin-angiotensin system (RAS) in the skin, leading to cutaneous side events.
- Reports of skin reactions associated with angiotensin antagonists are increasing.
Observation:
- A patient developed palmoplantar lesions while taking losartan.
- The skin lesions resolved after losartan treatment was discontinued.
Findings:
- The case suggests a potential causal link between losartan use and the development of palmoplantar lesions.
- Cutaneous side effects of angiotensin receptor antagonists can mimic various dermatological conditions.
Implications:
- Dermatologists and physicians should consider losartan and similar medications as a potential cause of unexplained skin eruptions.
- Awareness of these cutaneous reactions is crucial for accurate diagnosis and patient management.
- Further investigation into the mechanisms of RAS-mediated skin reactions is warranted.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...